يعرض 1 - 20 نتائج من 107 نتيجة بحث عن '(( ct ((largest decrease) OR (larger decrease)) ) OR ( 25 ((026 decrease) OR (nn decrease)) ))', وقت الاستعلام: 0.31s تنقيح النتائج
  1. 1

    Global Land Use Change Impacts on Soil Nitrogen Availability and Environmental Losses حسب Jing Wang (6206297)

    منشور في 2025
    "…In contrast, reversing managed to natural ecosystems significantly increased NNM by 20% (9.7, 25.4%) and decreased NN by 89% (−125, −46%), indicating increasing N availability while decreasing potential N loss. …"
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

    Summary of subgroup analysis results. حسب Junyin Pan (20700411)

    منشور في 2025
    "…The results showed that dietary anthocyanins significantly improved various lipid and glycemic markers:</p><p>HDL-C: increased by 0.05 mmol/L (95% CI: 0.01 to 0.10, p = 0.026), LDL-C: decreased by 0.18 mmol/L (95% CI: -0.28 to -0.08, p = 0.000), Triglycerides (TGs): reduced by 0.11 mmol/L (95% CI: -0.20 to -0.02, p = 0.021), Total cholesterol (TC): lowered by 0.34 mmol/L (95% CI: -0.49 to -0.18, p = 0.000), Fasting blood glucose (FBG): reduced by 0.29 mmol/L (95% CI: -0.46 to -0.12, p = 0.001), Glycated hemoglobin (HbA1c): decreased by 0.43% (95% CI: -0.74 to -0.13, p = 0.005). …"
  8. 8

    Original study data. حسب Junyin Pan (20700411)

    منشور في 2025
    "…The results showed that dietary anthocyanins significantly improved various lipid and glycemic markers:</p><p>HDL-C: increased by 0.05 mmol/L (95% CI: 0.01 to 0.10, p = 0.026), LDL-C: decreased by 0.18 mmol/L (95% CI: -0.28 to -0.08, p = 0.000), Triglycerides (TGs): reduced by 0.11 mmol/L (95% CI: -0.20 to -0.02, p = 0.021), Total cholesterol (TC): lowered by 0.34 mmol/L (95% CI: -0.49 to -0.18, p = 0.000), Fasting blood glucose (FBG): reduced by 0.29 mmol/L (95% CI: -0.46 to -0.12, p = 0.001), Glycated hemoglobin (HbA1c): decreased by 0.43% (95% CI: -0.74 to -0.13, p = 0.005). …"
  9. 9

    S2 File - حسب Junyin Pan (20700411)

    منشور في 2025
    "…The results showed that dietary anthocyanins significantly improved various lipid and glycemic markers:</p><p>HDL-C: increased by 0.05 mmol/L (95% CI: 0.01 to 0.10, p = 0.026), LDL-C: decreased by 0.18 mmol/L (95% CI: -0.28 to -0.08, p = 0.000), Triglycerides (TGs): reduced by 0.11 mmol/L (95% CI: -0.20 to -0.02, p = 0.021), Total cholesterol (TC): lowered by 0.34 mmol/L (95% CI: -0.49 to -0.18, p = 0.000), Fasting blood glucose (FBG): reduced by 0.29 mmol/L (95% CI: -0.46 to -0.12, p = 0.001), Glycated hemoglobin (HbA1c): decreased by 0.43% (95% CI: -0.74 to -0.13, p = 0.005). …"
  10. 10

    Data Sheet 1_Correlation analysis of osteoporosis and vertebral endplate defects using CT and MRI imaging: a retrospective cross-sectional study.pdf حسب Song Hao (5700608)

    منشور في 2025
    "…</p>Methods<p>Computed tomography (CT), magnetic resonance imaging (MRI), bone mineral density (BMD) and other relevant imaging data, as well as age, sex, body mass index (BMI), and degree of low back pain data, were retrospectively analysed. …"
  11. 11
  12. 12
  13. 13

    Annual number of outpatient visits in all eyes. حسب Yasuyuki Sotani (20114144)

    منشور في 2025
    "…In contrast, the non-recurrence group demonstrated significant and sustained improvement from 0.31 ± 0.25 preoperatively to 0.25 ± 0.25, 0.23 ± 0.26, 0.23 ± 0.28, 0.21 ± 0.27, 0.20 ± 0.30, and 0.16 ± 0.30 at corresponding postoperative time points (Kruskal-Wallis test, p < 0.001; <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0332941#pone.0332941.g005" target="_blank">Fig 5</a>).…"
  14. 14

    Time course of best-corrected visual acuity (BCVA) in recurrence and non-recurrence groups. حسب Yasuyuki Sotani (20114144)

    منشور في 2025
    "…In contrast, BCVA in the non-recurrence group significantly improved from 0.31 ± 0.25 preoperatively to 0.25 ± 0.25, 0.23 ± 0.26, 0.23 ± 0.28, 0.21 ± 0.27, 0.20 ± 0.30, and 0.16 ± 0.30 over the same time points (Kruskal–Wallis test, P < 0.001; Dunn’s test, *P < 0.05, **P < 0.01). …"
  15. 15
  16. 16
  17. 17

    Fig 26 - حسب Piotr Popik (292215)

    منشور في 2024
  18. 18

    Demographic information of participants. حسب Zixia Bu (21475019)

    منشور في 2025
    "…AB negatively affects T1 and T2 phase HSK (β = −0.25, β = −0.26). HSK negatively affects AB in T2 phase (β = −0.11). …"
  19. 19

    Key safety measures including adverse events. حسب Anuja Dokras (8679261)

    منشور في 2025
    "…As there is a lack of robust evidence on the impact of these first-line medications on cardiovascular disease (CVD) risk, we compared the effect of COCPs, metformin or both on prevalence of metabolic syndrome (MetS) in participants with hyperandrogenic PCOS and hypothesized that COCPs would increase prevalence of MetS while metformin would decrease prevalence of MetS.</p><p>Methods and findings</p><p>We conducted a multicenter, double-blind, double-dummy, randomized trial (COMET-PCOS) in participants between ages ≥18 and ≤40 years and body mass index (BMI) ≥25 kg/m<sup>2</sup> and ≤ 48 kg/m<sup>2</sup> with hyperandrogenic PCOS (defined by the Rotterdam criteria). …"
  20. 20

    Comparison of hemodynamic data. حسب Seung-Jae Joo (3620240)

    منشور في 2024
    "…Women showed higher E<sub>LV</sub>I (1.33±0.34 vs. 1.10±0.29 mmHg/ml∙m<sup>2</sup>, <i>P</i> = 0.004) and E<sub>A</sub>I (1.14±0.25 vs. 0.93±0.26 mmHg/ml∙m<sup>2</sup>, <i>P</i> = 0.001), but VAC was not different (women: 0.88±0.17 vs. men: 0.85±0.11, <i>P</i> = 0.431). …"